Risk modifiers for peripheral sensory neuropathy in HIV infection/AIDS
Authors:
- 28 January 2004
- journal article
- research article
- Published by Wiley in European Journal of Neurology
- Vol. 11 (2) , 97-102
Abstract
The objective of this study is to examine the risk factors associated with the development of sensory neuropathy in human immunodeficiency virus (HIV)‐infected patients in 292 HIV+ patients recruited through a community‐based sentinel survey. We determined the clinical and treatment factors associated with the presence of peripheral sensory neuropathy in HIV+ subjects at baseline examination, and at 1‐year follow‐up. Baseline examination was assessed with a logistic regression analysis controlling for age, education level, history of drug/alcohol use, and anti‐retroviral treatment. The risk of developing new peripheral neuropathy at follow‐up was determined using a Cox proportional hazard model analysis. At study entry, neuropathy (n = 64) was associated with acquired immunodeficiency syndrome (AIDS), nucleoside analogue reverse transcriptase inhibitors (NRTI) (i.e. ddC), and history of alcohol abuse. After 1‐year follow‐up, the development of neuropathy was predicted by AIDS, age (older subjects), and NRTI use.These findings indicated that AIDS, age, alcohol abuse/dependence, and anti‐retroviral medication use are important predictors of motor/sensory peripheral neuropathy in the HIV infection. The peripheral neurotoxic effect of anti‐retroviral medication should be taken into account in the design of long‐term therapies.Keywords
This publication has 23 references indexed in Scilit:
- Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infectionAIDS, 2000
- Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapyAIDS, 1999
- Neuromuscular function in HIV infectionAIDS, 1998
- Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cellsJournal of the Neurological Sciences, 1997
- Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: a longitudinal evaluationPsychological Medicine, 1997
- Neuropsychological abnormalities among HIV-infected individuals in a community-based sample.Neuropsychology, 1997
- Low-dose zalcitabine-related toxic neuropathyNeurology, 1996
- Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV‐1–infected individuals: Results from the multicenter AIDS cohort studyAnnals of Neurology, 1989
- Declining incidence of AIDS dementia complex after introduction of zidovudine treatment.BMJ, 1989
- Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patientsAnnals of Neurology, 1983